147 related articles for article (PubMed ID: 35738593)
1. Clinical Impact of Platelet-to-albumin Ratio on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Morita J; Hashimoto I; Ishiguro T; Onodera A; Cho H; Endo K; Onuma S; Kano K; Hara K; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1896-1902. PubMed ID: 35738593
[TBL] [Abstract][Full Text] [Related]
2. The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Onodera A; Morita J; Hashimoto I; Ishiguro T; Endo K; Cho H; Onuma S; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1916-1922. PubMed ID: 35738628
[TBL] [Abstract][Full Text] [Related]
3. The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Hashimoto I; Kano K; Hara K; Cho H; Segami K; Machida D; Nakazono M; Oshima T; Yukawa N; Rino Y
Anticancer Res; 2022 May; 42(5):2711-2717. PubMed ID: 35489731
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Ju M; Machida D; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Hara K; Segami K; Hashimoto I; Nagasawa S; Nakazono M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(3):1424-1431. PubMed ID: 35478112
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy.
Huang Z; Zheng Q; Yu Y; Zheng H; Wu Y; Wang Z; Liu L; Zhang M; Liu T; Li H; Li J
Sci Rep; 2022 Mar; 12(1):3535. PubMed ID: 35241740
[TBL] [Abstract][Full Text] [Related]
6. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
[TBL] [Abstract][Full Text] [Related]
7. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Kato A; Maezawa Y; Hashimoto I; Hara K; Komori K; Kawahara S; Numata M; Kazama K; Sawazaki S; Kamiya N; Yoshizawa S; Otani K; Tamagawa A; Cho H; Tamagawa H; Oshima T; Yukawa N; Saito A; Rino Y
Anticancer Res; 2024 Jan; 44(1):339-346. PubMed ID: 38159996
[TBL] [Abstract][Full Text] [Related]
9. The Albumin-Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
Ju M; Aoyama T; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Morita J; Onodera A; Endo K; Hashimoto I; Kano K; Hara K; Cho H; Nakazono M; Segami K; Ishiguro T; Onuma S; Oshima T; Yukawa N; Rino Y
Anticancer Res; 2022 Aug; 42(8):3929-3935. PubMed ID: 35896262
[TBL] [Abstract][Full Text] [Related]
10. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
[TBL] [Abstract][Full Text] [Related]
11. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
[TBL] [Abstract][Full Text] [Related]
14. The clinical impacts of lymphocyte-to-C-reactive protein ratio for esophageal cancer patients who receive curative treatment.
Aoyama T; Nagasawa S; Nakazono M; Segami K; Tamagawa H; Tamagawa A; Hara K; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023; 19(3):556-561. PubMed ID: 37470574
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of preoperative platelet-to-albumin ratio in surgically treated oral cavity cancer patients.
Tsai YT; Fang KH; Tsai MH; Lai CH; Ko CA; Tsai MS; Chang GH; Liao CT; Kang CJ; Hsu CM; Huang EI; Lee YC; Tsai YH; Luan CW
Head Neck; 2024 Feb; 46(2):386-397. PubMed ID: 38071495
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Cholangiocarcinoma.
Saito N; Shirai Y; Horiuchi T; Sugano H; Shiba H; Sakamoto T; Uwagawa T; Yanaga K
Anticancer Res; 2018 Feb; 38(2):987-992. PubMed ID: 29374731
[TBL] [Abstract][Full Text] [Related]
18. Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
Du KN; Feng L; Newhouse A; Mehta J; Lasala J; Mena GE; Hofstetter WL; Cata JP
Anesth Analg; 2018 Jul; 127(1):210-216. PubMed ID: 29757780
[TBL] [Abstract][Full Text] [Related]
19. The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.
Yukawa N; Aoyama T; Tamagawa H; Tamagawa A; Atsumi Y; Kawahara S; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Masuda M; Rino Y
In Vivo; 2020; 34(4):2087-2093. PubMed ID: 32606187
[TBL] [Abstract][Full Text] [Related]
20. Low Preoperative Albumin-to-Globulin Ratio Is a Marker of Poor Prognosis in Patients With Esophageal Cancer.
Atsumi Y; Kawahara S; Kakuta S; Onodera A; Hara K; Kazama K; Numata M; Aoyama T; Tamagawa A; Tamagawa H; Oshima T; Yukawa N; Rino Y
In Vivo; 2021; 35(6):3555-3561. PubMed ID: 34697194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
